Next-generation sequencing (NGS) of DNA from the BM aspirate of a panel of 28 genes, known to be pathogenic in MDS/MPN, detected mutations in CSF3R, SETBP1, and SRSF2, and a diagnosis of CNL was made (Tables 1 and 2). This evidence concerns the gene SRSF2 and myelodysplastic syndrome.